Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the ...
Glioblastoma (GBM), one of the most aggressive types of brain cancer, is one of the greatest challenges for medicine, both ...
GlobalData on MSN10d
Orphelia explores avenues for liquid neuroblastoma med after EU CHMP rejectionOrphelia Pharma is exploring alternative regulatory pathways for Kizfizo (temozolomide) following a negative opinion from the ...
Orphelia Pharma is exploring alternative regulatory pathways for KIZFIZO after receiving a negative opinion from the ...
WarwickshireWorld on MSN10d
Brindley Twist Tafft and James steps in to offer support to patients affected by extended use of temozolomide chemotherapyCoventry and Warwickshire’s leading medical negligence practitioners, is offering its professional support to patients ...
Trial to explore novel combination therapy for patients with recurrent Small Cell Lung Cancer who have failed frontline treatmentFully funded by the U.S. Veterans’ Administration Special Emphasis Pane ...
Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...
Elena Adams said she was put on temozolomide within days of being diagnosed with a brain tumour in 2016. Guidelines say the drug – which comes in tablet form – should be used on its own for up ...
As previously disclosed on November 14, 2024, Allarity’s (ALLR) cash position is expected to support operations into 2026. The $2.5 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback